Publisher
source

INSERM

Just Landed

Post-doctoral position - Cancer Screening Platform Inserm in France

Degree Level

Postdoc

Field of study

Oncology

Funding

Available

Deadline

Oct 31, 2026

Country flag

Country

France

University

INSERM

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

More information can be found here

Keywords

Oncology
Pharmacology
Biochemistry
Biology
Toxicology
Gene Expression
Medical Science
Cell Culture Techniques
Cancer Screening
Nuclear Receptor

Suggested positions

About this position

Inserm is offering a full-time postdoctoral position in Montpellier, France, within the IRCM (Institute for Research in Cancer of Montpellier) and its PCC research platform. The role sits in an oncology-focused environment that brings together researchers and clinicians to study tumorigenesis and develop new diagnostic and therapeutic strategies against cancer.

The successful postdoctoral researcher will join one of IRCM’s core technology platforms, dedicated to characterizing the activity of chemical compounds on nuclear receptors. The main scientific objective is to investigate how chemical molecules and environmental samples activate nuclear receptors, including the AhR receptor. This is a strong opportunity for candidates interested in chemical biology, toxicology, pharmacology, and cancer-related screening platforms.

Main activities include cell culture, performance of transactivation and proliferation assays, and measurement of gene expression by RT-PCR. The project therefore combines experimental cell-based assays with molecular readouts and screening approaches, with potential relevance for environmental health and oncology research.

Applicants should hold a PhD or equivalent in biological sciences or a related discipline. Essential experience includes cell culture and gene expression analysis, particularly reporter gene assays and RT-PCR. Additional experience in biochemistry, cell and molecular biology, medium-throughput screening of chemical compounds, and robotic workstations is highly valued. The post also favors candidates with backgrounds in pharmacology, toxicology, oncology, or endocrine disruption, and experience with the HepaRG cell line is a plus. Good English is required, together with teamwork, collaboration, publication writing, dynamism, and autonomy.

The position is temporary, full-time, and starts on 1 January 2027. The application deadline is 31 October 2026 at 20:00 (Europe/Paris). Applications are submitted by email to [email protected]. The position is located at Inserm/IRCM in Montpellier, France.

Funding details

Available

What's required

PhD or equivalent in a relevant field is required. Essential skills include proficiency in cell culture and gene expression analysis (reporter genes, RT-PCR). Desirable experience includes biochemistry, cell and molecular biology, medium-throughput screening of chemical compounds, and use/programming of robotic workstations. Candidates should be able to work in a team, manage collaborations with other teams, write publications, and demonstrate dynamism and autonomy. Prior experience in pharmacology, toxicology, oncology, or endocrine disruption is preferred, as is experience culturing the HepaRG cell line. Good English is required.

How to apply

Apply by email to [email protected] with the requested materials. Use the subject line shown in the apply link if relevant. Submit before 2026-10-31 at 20:00 Europe/Paris.

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?